Insight Molecular Diagnostics Inc. (IMDX) SEC filings
IMDX SEC filings moved a median of +3.49% by the close. IMDX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the IMDX overview →
23 measured IMDX SEC filing events.
Where these IMDX SEC filings landedvs 20 measured IMDX SEC filing reactions
| Middle 50% of IMDX SEC filing reactions | -4.68% to +7.09% |
|---|---|
| Median reaction (to close) | +3.49% |
| Measured reactions | 20 |
Point-in-time · zero look-ahead
Half of the 20 IMDX SEC filing events with a measured close landed between -4.68% and +7.09%; 65% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Insight Molecular Diagno For: Sep 15 | SEC filing · Form 8-K | +0.00% | +2.48% | |
| Form S-8 Insight Molecular Diagno | SEC filing · Form S-8 | -0.83% | -2.08% | |
| Form 8-K Insight Molecular Diagno For: Jun 11 | SEC filing · Form 8-K | +0.00% | +1.11% | |
| Form 10-Q Insight Molecular Diagno For: Mar 31 | SEC filing · Form 10-Q | +8.74% | +30.49% | |
| Form 8-K Insight Molecular Diagno For: May 13 | SEC filing · Form 8-K | +8.74% | +30.49% | |
| Form 8-K/A Insight Molecular Diagno For: Feb 20 | SEC filing · Form 8-K | +8.74% | +30.49% | |
| Form 8-K Insight Molecular Diagno For: Apr 30 | SEC filing · Form 8-K | -3.38% | +4.50% | |
| Form ARS Insight Molecular Diagno For: Dec 31 | SEC filing · Form ARS | -3.38% | +4.50% | |
| Form DEF 14A Insight Molecular Diagno For: Apr 30 | SEC filing · Form DEF | -3.38% | +4.50% | |
| Form DEFA14A Insight Molecular Diagno | SEC filing · Form DEFA14A | -3.38% | +4.50% | |
| Form 10-K Insight Molecular Diagno For: Dec 31 | SEC filing · Form 10-K | -3.96% | -14.63% | |
| Form 8-K Insight Molecular Diagno For: Mar 26 | SEC filing · Form 8-K | -3.96% | -14.63% | |
| Form 8-K Insight Molecular Diagno For: Feb 20 | SEC filing · Form 8-K | -0.17% | +5.07% | |
| Form 8-K Insight Molecular Diagno For: Feb 10 | SEC filing · Form 8-K | -2.01% | -6.86% | |
| Form 8-K Insight Molecular Diagno For: Feb 11 | SEC filing · Form 8-K | -7.38% | -10.05% | |
| Form 10-Q Insight Molecular Diagno For: Sep 30 | SEC filing · Form 10-Q | -2.26% | +13.16% | |
| Form 8-K Insight Molecular Diagno For: Nov 10 | SEC filing · Form 8-K | -2.26% | +13.16% | |
| Form 8-K Insight Molecular Diagno For: Sep 28 | SEC filing · Form 8-K | +2.46% | +0.90% | |
| Form 8-K Insight Molecular Diagno For: Sep 16 | SEC filing · Form 8-K | -0.59% | -4.11% | |
| Form S-8 Insight Molecular Diagno | SEC filing · Form S-8 | +3.40% | — | |
| Form 10-Q Insight Molecular Diagno For: Jun 30 | SEC filing · Form 10-Q | +0.00% | — | |
| Form 8-K Insight Molecular Diagno For: Aug 11 | SEC filing · Form 8-K | +0.00% | — | |
| Form 8-K Insight Molecular Diagno For: Jun 27 | SEC filing · Form 8-K | +0.82% | -6.40% |
Keep exploring
More IMDX: earnings → · analyst actions → · IMDX overview →